Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2010 1
2015 3
2016 2
2017 1
2019 2
2021 1
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Dental implants in patients suffering from autoimmune diseases: A systematic critical review.
Esimekara JO, Perez A, Courvoisier DS, Scolozzi P. Esimekara JO, et al. J Stomatol Oral Maxillofac Surg. 2022 Oct;123(5):e464-e473. doi: 10.1016/j.jormas.2022.01.005. Epub 2022 Jan 13. J Stomatol Oral Maxillofac Surg. 2022. PMID: 35033725 Free article.
RESULTS: Fifty-five studies reporting on nine distinct autoimmune diseases were analyzed: 17 on Sjogren's syndrome (SS), 11 on oral lichen planus (OLP), 8 on Type 1 diabetes, 6 on rheumatoid arthritis (RA), 4 on systemic scleroderma (SSc), 3 on Crohn's disease (CD), 3 on systemic …
RESULTS: Fifty-five studies reporting on nine distinct autoimmune diseases were analyzed: 17 on Sjogren's syndrome (SS), 11 on oral lichen p …
Brunsting-Perry pemphigoid: a systematic review.
Aromolo IF, Maronese CA, Moltrasio C, Genovese G, Marzano AV. Aromolo IF, et al. Int J Dermatol. 2022 Nov;61(11):1353-1358. doi: 10.1111/ijd.16045. Epub 2022 Jan 20. Int J Dermatol. 2022. PMID: 35049061 Review.
BACKGROUND: Brunsting-Perry pemphigoid (BPP) is a rare, autoimmune bullous skin disorder classified within the spectrum of mucous membrane pemphigoid (MMP). MATERIALS AND METHODS: An a priori protocol was designed based on PRISMA guidelines. ...
BACKGROUND: Brunsting-Perry pemphigoid (BPP) is a rare, autoimmune bullous skin disorder classified within the spectrum of mucous …
Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review.
Lytvyn Y, Rahat S, Mufti A, Witol A, Bagit A, Sachdeva M, Yeung J. Lytvyn Y, et al. J Am Acad Dermatol. 2022 Jul;87(1):110-120. doi: 10.1016/j.jaad.2020.12.056. Epub 2021 Jan 7. J Am Acad Dermatol. 2022. PMID: 33422625 Review.
BACKGROUND: Mucous membrane pemphigoid (MMP) is an autoimmune disease that can lead to fibrosis of mucous membranes and functional impairment. ...
BACKGROUND: Mucous membrane pemphigoid (MMP) is an autoimmune disease that can lead to fibrosis of mucous membranes and …
Laryngeal mucous membrane pemphigoid: a systematic review and pooled-data analysis.
Higgins TS, Cohen JC, Sinacori JT. Higgins TS, et al. Laryngoscope. 2010 Mar;120(3):529-36. doi: 10.1002/lary.20763. Laryngoscope. 2010. PMID: 20058317 Review.
OBJECTIVES/HYPOTHESIS: To perform a systematic pooled-data analysis of literature data involving laryngeal mucous membrane pemphigoid (MMP). STUDY DESIGN: A systematic review and pooled-data analysis. ...
OBJECTIVES/HYPOTHESIS: To perform a systematic pooled-data analysis of literature data involving laryngeal mucous membrane …
Periodontitis in oral pemphigus and pemphigoid: A systematic review of published studies.
Jascholt I, Lai O, Zillikens D, Kasperkiewicz M. Jascholt I, et al. J Am Acad Dermatol. 2017 May;76(5):975-978.e3. doi: 10.1016/j.jaad.2016.10.028. Epub 2016 Dec 28. J Am Acad Dermatol. 2017. PMID: 28038889 Review.
Periodontitis and autoimmune bullous diseases, including pemphigus vulgaris and mucous membrane pemphigoid, are immunoinflammatory disorders leading to microbial plaque- and autoantibody-elicited tissue injury of the oral cavity, respectively. ...This review …
Periodontitis and autoimmune bullous diseases, including pemphigus vulgaris and mucous membrane pemphigoid, are immunoi …
Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.
Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Kirtschig G, et al. Cochrane Database Syst Rev. 2003;2003(1):CD004056. doi: 10.1002/14651858.CD004056. Cochrane Database Syst Rev. 2003. PMID: 12535507 Free PMC article. Review.
BACKGROUND: Mucous membrane pemphigoid and epidermolysis bullosa acquisita are acquired autoimmune blistering diseases of the skin. ...REVIEWER'S CONCLUSIONS: There is limited evidence (from two small trials) that severe ocular mucous membrane …
BACKGROUND: Mucous membrane pemphigoid and epidermolysis bullosa acquisita are acquired autoimmune blistering diseases …
Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Kirtschig G, et al. Arch Dermatol. 2002 Mar;138(3):380-4. doi: 10.1001/archderm.138.3.380. Arch Dermatol. 2002. PMID: 11902989 Review.
OBJECTIVE: To identify and critically evaluate evidence from randomized controlled trials for the efficacy of treatments for mucous membrane pemphigoid (MMP)/cicatricial pemphigoid (CP) and epidermolysis bullosa acquisita (EBA). ...
OBJECTIVE: To identify and critically evaluate evidence from randomized controlled trials for the efficacy of treatments for mucous …
Ocular cicatricial pemphigoid.
Hingorani M, Lightman S. Hingorani M, et al. Curr Opin Allergy Clin Immunol. 2006 Oct;6(5):373-8. doi: 10.1097/01.all.0000244799.33734.d4. Curr Opin Allergy Clin Immunol. 2006. PMID: 16954792 Review.
PURPOSE OF REVIEW: To review the content and importance of articles on ocular cicatricial pemphigoid (OCP), or mucous membrane pemphigoid (MMP) with relevance to ocular involvement, published from 2005 to 2006. ...
PURPOSE OF REVIEW: To review the content and importance of articles on ocular cicatricial pemphigoid (OCP), or mucous membrane …
A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
Kianfar N, Dasdar S, Daneshpazhooh M, Aryanian Z, Goodarzi A. Kianfar N, et al. Exp Dermatol. 2023 Jul;32(7):934-944. doi: 10.1111/exd.14829. Epub 2023 May 7. Exp Dermatol. 2023. PMID: 37150538 Review.
Disease remission with IVIg therapy and RTX + IVIg combination therapy were recorded as 82.8% and 86.7% in pemphigus, 88.0% and 100% in bullous pemphigoid and 91.3% and 75.0% in mucous membrane pemphigoid, respectively. In epidermolysis bullosa acquisita, tre …
Disease remission with IVIg therapy and RTX + IVIg combination therapy were recorded as 82.8% and 86.7% in pemphigus, 88.0% and 100% in bull …
A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA.
Amber KT, Bloom R, Hertl M. Amber KT, et al. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):72-7. doi: 10.1111/jdv.13397. Epub 2015 Oct 7. J Eur Acad Dermatol Venereol. 2016. PMID: 26446477 Review.
BACKGROUND: Mucous membrane pemphigoid (MMP) is characterized by subepithelial blistering due to IgG autoantibodies targeting various components of the dermal-epidermal basement membrane zone. ...
BACKGROUND: Mucous membrane pemphigoid (MMP) is characterized by subepithelial blistering due to IgG autoantibodies tar …
17 results